State Ledger
Company profile

SpyGlass Pharma, Inc. CIK 1778922

Ticker
SGP (Nasdaq)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Irvine, CA 92618
Fiscal year end
2025 (FY)
Market Data
Close
$24.84
Change
-$0.07
Change %
-0.28%
Volume
3,360

SGP · trading date Oct 12, 2026 · previous close $24.91 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$39.87M
Total assets
$115.87M
Total liabilities
$10.17M
Stockholders' equity
-$98.84M
Cash & equivalents
$96.36M
Operating income
-$41.45M
Operating cash flow
-$32.70M
Capital expenditures
$789.0K

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$33.49M
Free cash flow margin
—
Liabilities / assets
8.8%
Equity / assets
-85.3%
CapEx / revenue
—
Operating cash flow / net income
0.82×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$39.87M $115.87M $10.17M -$98.84M
2024 — -$29.16M $23.32M $11.25M -$60.47M
Company Details
SIC code
3841
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-06
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Irvine, CA 92618
15326 ALTON PARKWAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies